TipHub

₹615.05

▲ +28.23 +4.81%

23 Sept 2026

BSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-09-23

Hemant Surgical Industries Ltd. (543916)

Volume: 1,12,400Avg Vol 1W: 1,06,960Avg Vol 1M: 59,94552W Range:₹215₹616.5
BSE www.hemantsurgical.com
Key Ratios
Checked 1h ago
Market Cap—
Current Price₹615.05
Previous Close₹586.82
High / Low (52w)₹616.5 / ₹215
Volume1,12,400
Avg Vol (1W)1,06,960
Avg Vol (1M)59,945
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity0.49
50 DMA₹395.65
200 DMA₹333.17
Day change+4.81%
SurveillanceLT-ASM · ASM 1
Price Chart
₹615.05▲ 77.97% · 1Y
₹615₹1493.1L
2025-09-23
2026-09-23

20-day avg volume: 62K shares

Pros
  • Company is almost debt-free.
Profit & Loss (Annual)
MetricMar 2025
Revenue₹112 Cr
EBITDA₹13 Cr
Net Profit₹8 Cr
EPS7.7
Balance Sheet
MetricMar 2025
Total Assets₹148 Cr
Total Liabilities₹85 Cr
Equity₹63 Cr
Total Debt—
Cash Flow
MetricMar 2025
Operating₹11 Cr
Investing₹-30 Cr
Financing₹18 Cr
Free Cash Flow₹11 Cr
Shareholding
Promoter 52.83% Institutions 20.07% Public 27.1%
Efficiency & Working Capital
ROCE—
Interest Coverage5.5
Dividend Payout—
Debtor Days70 d
Inventory Days148 d
Payable Days133 d
Cash Conversion Cycle84 d
Working Capital Days217 d
Shareholding Details

As of 2026-05-31

Promoter52.8%
FII0.1%
DII19.9%
Institutions20.1%
Public27.1%
Promoter Pledge0%
No. of Shareholders948
Shareholding Pattern

Quarterly — figures in %. Latest 9 quarters.

PeriodJun 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Mar 2026May 2026
Promoters73.6%73.6%73.6%73.6%73.6%58.9%58.9%52.8%52.8%
FIIs2.4%0%0%0%0.4%0.2%0.2%0.1%0.1%
DIIs0.5%0%2%1.1%1.1%10.8%10.8%9.6%19.9%
Public23.5%26.4%24.5%25.3%24.9%30.1%30.1%37.4%27.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%
No. of Shareholders8307221,2291,2481,229748758948948
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Hanskumar Shamji ShahShareholding of Promoter and Promoter Group24.3%35,26,400
Kaushik Hanskumar ShahShareholding of Promoter and Promoter Group14.5%21,03,120
Hemant Praful ShahShareholding of Promoter and Promoter Group11.9%17,34,080
Singularity Equity Fund IPublic Shareholding6.2%8,99,200
Singularity Large Value Fund IiiPublic Shareholding6.2%8,99,200
Singularity Large Value Fund IPublic Shareholding3.4%5,00,000
Wealthwave Capital Trust-wealthwave Capital FundPublic Shareholding2.8%4,00,000
Mona LaroiaPublic Shareholding2.3%3,37,200
Renu Devi HisariaPublic Shareholding2.1%3,00,000
Swati PokharnaPublic Shareholding2.1%3,00,000
Singularity Equity Fund IiPublic Shareholding1.4%2,00,000
Bimla BajajPublic Shareholding1.4%2,00,000
Naresh SaraafPublic Shareholding1.1%1,59,200
Naman Hemant ShahShareholding of Promoter and Promoter Group0.7%95,200
Leena Hanskumar ShahShareholding of Promoter and Promoter Group0.6%87,920
Neha Hanskumar ShahShareholding of Promoter and Promoter Group0.5%77,760
Neha Hemant ShahShareholding of Promoter and Promoter Group0.4%55,520
Board of Directors
NameDesignationYear
HANSKUMAR SHAMJI SHAHChairman / Executive Director / Managing Director2025
HEMANT PRAFUL SHAHExecutive Director / Whole Time Director / CFO2025
HANS KAUSHIK KUMAR SHAHExecutive Director / Whole Time Director / CFO2025
Nehal Babu KareliyaNon Executive Director2025
Kshama DharnidharkaIndependent Non Exe. Director2025
Manish KankaniIndependent Non Exe. Director2025
Meenal AjmeraCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10111010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20250003915
2025000114
2025000203
Substantial Acquisitions (SAST)

2 disclosure(s)

Allotment Of Warrants On Preferential Basis15/05/2026 · 6,49,600
Allotment Of Warrants On Preferential Basis15/05/2026 · 6,49,600
Company Information
Incorporated1989
ChairmanHANSKUMAR SHAMJI SHAH
AuditorA D V & Associates
Investor Email[email protected]
🌐 www.hemantsurgical.com ↗

📍 502 5thFloor Ecstacy Bus.Park, JSD Road Mulund West, Mumbai, Maharashtra, 400080

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Avalon TechnologiesSancode Technologies LimitedRetina Paints LimitedInnokaiz India LimitedPower & InstrumentationSwati Projects LimitedCFF Fluid Control LimitedComrade Appliances LimitedSonalis Consumer Products Ltd.Maple Infrastructure TrustBizotic Commercial LimitedAsian Warehousing LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search